Combined Checkpoint Inhibition In HCC & Biliary Tract Cancer

Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses Combined Checkpoint Inhibition In HCC & Biliary Tract Cancer. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com